Interestingly, on meta-analysis of non-selective NSAIDs, there was only a slight trend for IBD relapse, which was not statistically significant (relative risk 1.29, 95% confidence interval 0.92–1.80).
1
—
—
Interestingly, on meta-analysis of non-selective NSAIDs, there was only a slight trend for IBD relapse, which was not statistically significant (relative risk 1.29, 95% confidence interval 0.92–1.80).